Sanofi invests $294M to expand AI Center of Excellence in Toronto and accelerate innovation for patients
Sanofi becomes market authorization holder for Nuvaxovid® in Canada, expanding COVID-19 vaccine choices for Canadians
Rezurock® now reimbursed in Ontario and British Columbia for people living with chronic graft-versus-host disease
UPDATE - Medidata Extends Collaboration with Sanofi for the Development of New Therapies with an Improved Patient Journey
Sanofi Deepens Partnership with Medidata to Expedite the Development of New Therapies with an Improved Patient Journey
Sanofi's high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose
Sanofi expands patient affordability program by offering access to all its insulins for $35 per month in the US
VVC Exploration Corporation Announces Application For Management Cease Trade Order And Provides Financing Update
Goldgroup Announces Nominees to Board in Connection with Proposed Business Combination with Gold Resource Corporation and Amends Arrangement Agreement
